Skip to main content

The optician sorts the eyes. The dentist sorts the teeth. The GP mentions the menopause. Everybody is helpful, everybody is doing their job properly, and nobody is looking at the whole person.

That is how Sjögren’s disease hides in Ireland. It is one of the most common autoimmune conditions there is, it usually announces itself in midlife, and its two headline symptoms are dry eyes and a dry mouth: two complaints that get sent to two different buildings and treated as unrelated nuisances. On average, people wait roughly five to six years from first symptoms to diagnosis, according to a 2026 review of the condition’s unmet needs published in Cureus. Five years is a long time to be told you are grand.

TL;DR

  • Sjögren’s disease is an autoimmune condition in which the immune system attacks the glands that make tears and saliva. It affects women around 9 to 10 times more often than men and often starts around the time of the menopause, which is exactly why it gets missed.
  • The average delay from first symptoms to diagnosis is about five to six years, largely because dry eyes and dry mouth are treated separately by separate professionals.
  • At 27 August 2026 there were 17,017 adults on the Irish public waiting list for a first rheumatology outpatient appointment, 1,395 of them waiting more than 18 months (NTPF figures). There is plenty you can do while you wait.
  • Sjögren’s is not one of the 16 conditions on the Long-Term Illness Scheme, so eye drops, saliva products and high-fluoride toothpaste are paid for through the Drugs Payment Scheme (€80 a month cap) or a medical card.
  • Salagen, the tablet whose licensed Irish indication was literally dry mouth and dry eyes in Sjögren’s syndrome, had its Irish licence withdrawn on 13 November 2008 and has not been replaced.
  • Long-term Sjögren’s carries a genuinely raised risk of non-Hodgkin lymphoma, which is the main reason it is worth naming rather than tolerating.

What Sjögren’s disease actually is

In Sjögren’s disease, white blood cells infiltrate the glands that produce moisture, chiefly the lacrimal glands behind the upper eyelids and the salivary glands in the cheeks and under the jaw. Those glands gradually stop doing their job. The result is persistent dryness of the eyes and mouth, often with vaginal dryness as well, which is one more reason the menopause gets the blame.

It is not only a dryness condition. Arthritis Ireland, which is the main Irish patient organisation covering it, describes Sjögren’s as systemic: it can involve the joints, muscles, blood vessels, lungs, kidneys and peripheral nerves. Fatigue, joint pain and Raynaud’s phenomenon are all common companions.

Two bits of terminology will come up. It is now generally called Sjögren’s disease rather than syndrome, and the old split into “primary” and “secondary” Sjögren’s, depending on whether it appeared alongside rheumatoid arthritis or lupus, is used far less than it once was. If your consultant uses the newer language and your reading uses the older, it is the same condition.

Why it hides so well after 50

Dryness in your fifties has three ready-made explanations, and every one of them is plausible enough to stop the search.

The menopause. Symptoms frequently begin around the time oestrogen levels fall, so the timing fits perfectly. The trouble is that it fits perfectly whether or not you also have an autoimmune condition. If you want the wider picture on this stage of life, our guide to women’s health after 50 covers the ground.

Medication. Dozens of ordinary medicines dry you out, particularly those with anticholinergic effects: bladder tablets, older antihistamines, some antidepressants, certain Parkinson’s drugs. This is a real and frequently correct explanation, and it is worth working through properly with a pharmacist. We have written about the anticholinergic burden in detail. But “your tablets are drying you out” and “you have an autoimmune disease” are not mutually exclusive, and the first answer often ends the conversation.

Ageing itself. Tear production does decline with age, and plenty of people over 60 have dry eyes without any autoimmune disease, as our guides to dry eyes and dry mouth explain. The distinguishing feature is not the dryness. It is the combination, the persistence, and the company it keeps.

Six questions worth answering honestly

Arthritis Ireland suggests a set of questions to bring to your GP. Say yes to several of these and it is reasonable to ask whether further testing is warranted:

  • Have your eyes felt dry every day for more than three months?
  • Do they feel gritty, as though there is sand in them?
  • Are you using artificial tears more than three times a day?
  • Is your mouth noticeably dry most days?
  • Do the glands near your jaw or in front of your ears swell?
  • Do you need to drink liquids to get dry food down?

Add the supporting cast: unexplained fatigue that sleep does not fix, aching joints, new dental decay in a mouth that has behaved itself for fifty years, recurrent oral thrush, a dry cough, hoarseness after talking for a while, or numbness and burning in the hands and feet.

What testing looks like in Ireland

Your GP is the right starting point, and the first round is straightforward. Blood tests look for specific autoantibodies, most importantly anti-Ro (also written anti-SSA). An eye assessment measures tear production and the health of the eye surface, and saliva flow can be measured too. Depending on the picture, you may be referred for an ultrasound of the salivary glands, or for a lip biopsy, in which a tiny sample of gland tissue is taken from inside the lower lip and examined for the clusters of immune cells that characterise the disease.

One point deserves emphasis, because it ends too many investigations prematurely: a negative antibody test does not rule Sjögren’s out. A meaningful proportion of people with the disease are antibody-negative, which is precisely why biopsy and imaging exist in the diagnostic criteria. If your bloods come back clear and your symptoms do not, that is a reason to keep asking, not to stop.

Then there is the access problem. The National Treatment Purchase Fund’s own figures for 27 August 2026 show 17,017 adults waiting for a first rheumatology outpatient appointment in the public system, 1,395 of them waiting longer than 18 months. Ophthalmology, the other relevant door, had 41,701 adults waiting. Those are not reasons to skip the referral, but they are reasons to be realistic about the timeline and to use the waiting period well. Our guide to navigating healthcare waiting lists covers how to check and chase your place.

The money nobody mentions

Sjögren’s is a lifelong condition that needs daily products: lubricating eye drops, saliva substitutes or sprays, high-fluoride toothpaste. Here is the part that catches people out.

The Long-Term Illness Scheme, which provides free medicines and appliances for a named condition with no means test, covers exactly 16 conditions: acute leukaemia, cerebral palsy, cystic fibrosis, diabetes insipidus, diabetes mellitus, epilepsy, haemophilia, hydrocephalus, intellectual disability, mental illness under 16, muscular dystrophy, multiple sclerosis, parkinsonism, phenylketonuria, spina bifida and thalidomide conditions. Sjögren’s disease is not on that list, and neither is any other autoimmune rheumatic disease.

So unless you hold a medical card, your Sjögren’s costs run through the Drugs Payment Scheme, which caps a household’s monthly outlay on prescribed medicines and certain appliances at €80. That threshold has been €80 since 1 March 2022. Use the same pharmacy within a month where you can, because spreading purchases across two can push you over the cap, and claim the excess back with a refund form if it happens.

The dental part that actually matters

Saliva buffers acid, washes away food debris and carries the minerals that repair early damage to enamel. Take it away and decay accelerates, often in places a dentist would not normally expect it, such as the gumline and the biting edges of front teeth. People with long-standing Sjögren’s can lose teeth that were perfectly sound at 50. This is the complication most worth getting ahead of, and the general rules of dental health after 50 are not enough on their own.

What the Irish schemes give you, and what to ask for:

  • With a medical card, the Dental Treatment Services Scheme covers a free examination each calendar year, any necessary extractions, two fillings a year, and one scale and polish a year.
  • The clause worth knowing: patients with special needs or in a high-risk category may receive cleaning every six months instead, subject to approval by the local HSE Principal Dental Surgeon. The examples usually quoted are diabetes and cancer treatment. Sjögren’s is not named, so nobody will offer it to you. Ask your dentist to make the case.
  • With PRSI contributions, the Treatment Benefit Scheme pays the full cost of one oral examination a calendar year. Since 31 January 2026 it also pays €50 towards a scale and polish (with your own balance capped at €15) or €42 towards periodontal treatment where clinically necessary, once a year.

Between those two schemes, the State funds roughly one clean a year. A mouth that makes no saliva usually needs three or four visits a year, plus high-fluoride toothpaste on prescription. Budget for the gap, and tell your dentist the diagnosis the day you get it, because the preventive plan changes completely.

The medicine Ireland quietly stopped licensing

Here is a detail that rarely makes it into patient leaflets. There is a tablet, pilocarpine, sold as Salagen 5mg, whose licensed Irish indication was written in plain terms in its own Summary of Product Characteristics: treatment of symptoms of dry mouth and dry eyes in patients with Sjögren’s syndrome.

Its Irish licence, PA0013/107/001, was withdrawn on 13 November 2008, and the Health Products Regulatory Authority’s medicines database still says so. Ireland has gone close to two decades without a marketed, nationally licensed tablet for the central symptom of a common autoimmune disease. The only other pilocarpine products on the Irish list are eye drops used for an entirely different purpose.

That does not mean nothing can be done. Saliva stimulation, prescription eye drops that reduce inflammation on the eye surface, punctal plugs that slow tear drainage, and hydroxychloroquine for joint pain and fatigue are all part of routine management, and a rheumatologist can discuss what is available and how it would be sourced. It does mean you should go in with realistic expectations: internationally, there is still no approved disease-modifying treatment for Sjögren’s, and care remains largely symptomatic. Several targeted drugs (ianalumab, nipocalimab and dazodalibep among them) have produced promising results in randomised trials, so this may be a different conversation in five years.

The reason to take it seriously

Most people with Sjögren’s live normally for decades. But the condition drives persistent B-cell activation, and over many years that carries a measurable risk of non-Hodgkin lymphoma.

A Spanish prospective cohort published in 2025 followed 314 patients for a median of 9.5 years. Eleven of them, 3.5%, developed non-Hodgkin lymphoma, a standardised incidence ratio of 15.36 compared with the general population. The strongest single predictor was cryoglobulinaemia, a specific blood abnormality your consultant can test for.

Read that as 96.5% did not, over nearly a decade. The useful conclusion is not fear, it is follow-up: a named diagnosis means someone is checking the right bloods. In particular, a salivary gland near the jaw or in front of the ear that swells and stays swollen, rather than coming and going, is worth reporting promptly rather than monitoring privately.

The symptoms people are told are unrelated

An international patient survey published in 2026 in Rheumatology collected 4,050 responses from people with Sjögren’s across 60 countries. Every single respondent reported at least one neurological symptom from the survey list, yet only 21.6% of symptomatic patients had ever received a formal diagnosis of neurological involvement. Half of all respondents felt their healthcare providers underestimated these symptoms.

Numbness and burning in the feet, nerve pain, brain fog and crushing fatigue are not side issues people are imagining. They are documented features of the disease, and they are under-recognised everywhere, not only here. If you have the diagnosis and these symptoms, say so plainly and ask for them to be recorded.

What you can do this month

  • Write down how long the dryness has been going on, in both eyes and mouth, and bring the six questions above to your GP as one conversation rather than two appointments.
  • Ask specifically whether anti-Ro (SSA) antibodies have ever been tested, and ask what happens next if they are negative.
  • Book a dental appointment and say the word Sjögren’s, even if it is still only a suspicion. Ask about the six-monthly high-risk pathway and about high-fluoride toothpaste.
  • Register for the Drugs Payment Scheme at mydps.ie if you do not have a medical card, before the costs start.
  • Ring the Arthritis Ireland helpline on 0818 252 846. They cover Sjögren’s, and their Living Well with Arthritis self-management course is open to people with related conditions.

A last word

Five or six years is the average delay. Dry eyes plus dry mouth, persisting, in your fifties or sixties, is a pattern worth naming out loud at your next GP visit.

At Críonna Health we write about the conditions that get filed under getting older when they are nothing of the sort. If this one sounds familiar, the next appointment is the place to start.

This article is for general information and is not a substitute for individual medical advice. If you are concerned about your symptoms, speak with your GP.

📷 Photo by manu schwendener on Unsplash

Leave a Reply